Psychiatric medications are often prescribed to young women who are not warned that these drugs can be extremely difficult to stop. Yet taking these drugs during pregnancy is risky. Learn more about psychiatric medications and pregnancy risks below.
A 2018 study found that ADHD medication use (including methylphenidate and amphetamine salts) in pregnancy was associated with up to a three-fold increased risk of at least 3 different birth defects: gastroschisis, omphalocele, and transverse limb deficiency.
A 2014 study found that use of mood stabilizers and antipsychotics during pregnancy was associated with a three-fold increased risk of newborn health problems resulting in special care/intensive care for the baby. Respiratory distress, pre-term births, cognitive abnormalities, and withdrawal symptoms in the baby were all associated with use of these drugs.
A 2019 report by France’s National Agency for the Safety of Medicines (ANSM) found that valproate (Depakote) use in pregnancy is associated with a five-fold increase in birth defect risk. “Valproate is the antiepileptic which causes the most malformations. It also leads to a high risk of neurodevelopmental disorders (cognitive and behavioural).” Topiramate (Topamax) increased the risk three-fold.
A 2014 study found a four-fold increase in “severe congenital heart defects” in newborns who were exposed to SSRIs in the womb.
A 2016 study used EEG to assess newborn brain function. Newborns who had been exposed to SSRIs while in the womb had multiple “abnormalities” in brain function. Maternal depression and anxiety were not associated with these abnormalities. Only SSRI use was.